Bristol-Myers Squibb: Drug Donations and Philanthropic Efforts
Drug Donations and Other Philanthropic Efforts: A Special Focus on HIV, Hepatitis and Cancer Care in Parts of the Developing World

The Bristol-Myers Squibb Foundation's mission is to promote health equity and improve the health outcomes of populations disproportionately affected by serious diseases and conditions by strengthening community-based health care worker capacity, integrating medical care and community-based supportive services and mobilizing communities in fighting disease. Leveraging public-private partnerships, the Foundation focuses on improving health outcomes of populations disproportionately affected by HIV/AIDS in Africa, hepatitis B and hepatitis C in Asia, type 2 diabetes in the U.S., and cancer in Central and Eastern Europe. The Foundation also supports the mental health and community reintegration needs of veterans, military service members, their families and families of the fallen in the United States. It therefore focuses on five disease areas in four geographies. Bristol-Myers Squibb understands that only by removing barriers to care and by supporting patients over the course of their disease can its innovative medical treatments achieve their maximum impact.

Product Donations: Asia, Latin America, Middle East and Africa

Product Donations: In 2013, the company donated products with a wholesale value of over $66 million. More than $17 million in product donations went to the Asia/Pacific region, more than $22 million to Latin America and the Caribbean and nearly $9 million went to countries in the Middle East and Africa. Donations were distributed through AmeriCares, Direct Relief International, Project HOPE, the National Cancer Coalition, Medical Teams International, MAP International and the Catholic Medical Mission Board. Among the products donated were cardiovascular products, antibiotics and therapeutic creams.

HIV/AIDS, TB, Cervical & Breast Cancer Screenings in Africa

  • The Bristol-Myers Squibb Foundation’s SECURE THE FUTURE Technical Assistance and Skills Transfer Program (TAP), launched in 2007, evolved from the Foundation’s groundbreaking initiative to enhance medical research and care and community-based outreach and support for women and children affected and infected by HIV in sub-Saharan Africa. Launched in 1999 with a $100 million commitment, the largest in Africa by a corporate foundation, SECURE THE FUTURE initially worked with partners in five countries. Today, SECURE THE FUTURE is engaged in more than 50 projects in 15 countries and the total commitment has grown to $165 million. Over the past 15 years, SECURE THE FUTURE has built a lasting legacy that includes the creation of Children’s Clinical Centers of Excellence in five countries and the training of hundreds of health care providers across the continent.

    TAP provides technical assistance, capacity-building tools and seed funding to extend community-based approaches to fighting HIV/AIDS. This is especially important as billions more in funding have flowed into Africa and organizations are challenged to use these funds as effectively as possible. TAP’s faculty of 50 experts – themselves SECURE THE FUTURE grant recipients and partners in eight countries – help non-governmental organizations (NGOs) enhance their community engagement and program management skills.

    TAP has increased SECURE THE FUTURE’s impact by employing a “South to South” model of skill- and knowledge transfer across Africa using human resources and community-based solutions. Partnerships with governments, NGOs, individual experts and partner organizations are central to TAP, whose current projects include community mobilization, voluntary counseling and testing, orphan and vulnerable children programs, prevention of mother to child transmission of HIV, income generation programs, HIV management, home-based care and psycho-social support. Since the start of 2013, TAP has received $3.5 million in funding from the Foundation. Since its inception, TAP has received nearly $10 million. READ MORE.

    In 2011, the Committee Encouraging Corporate Philanthropy presented a President’s Award, its highest honor, to TAP during its 11th annual Excellence Awards program.
  • Responding to the United Nations’ Call to Action for Women and Children in Africa:
    SECURE THE FUTURE has long served as an important platform for Bristol-Myers Squibb’s commitment to the health of women and children. In late 2011, responding to a call to action by the United Nations to focus on “Every Woman, Every Child,” the company announced an expansion of those efforts. Its sixth clinical center of excellence, dedicated to treating HIV-infected children and their families, is being located in one of Kenya’s highest HIV prevalence areas. As in other countries, the center will help expand Kenya’s response to pediatric HIV/AIDS through treatment and care, as well as technical support and guideline development. The Foundation also committed to increase TAP trainings relating to orphans and vulnerable children as well as to grandmother empowerment. Work in these areas will be expanded in Swaziland and in the Democratic Republic of the Congo.
    The Bristol-Myers Squibb Foundation also is a founding member of the Pink Ribbon Red Ribbon women’s health initiative, a major public-private initiative announced in September 2011 by the U.S. Department of State, Susan G. Komen for the Cure, the George W. Bush Institute, PEPFAR and UNAIDS. Pink Ribbon Red Ribbon seeks to leverage existing HIV infrastructure and platforms in sub-Saharan Africa and Latin America to help combat cervical and breast cancers. The Foundation has committed $1.2 million over three years and has expanded the focus of its SECURE THE FUTURE program to include cervical cancer. In Tanzania, with the Foundation’s support, five community-based organizations will screen more than 50,000 women between ages 30 and 50 years and those living with HIV for cervical and breast cancer as well as refer 600 for treatment at regional hospitals.
  • Capacity-Building: Good Clinical Practices – About 2,500 health care professionals have been trained on Good Clinical Practices (GCP) at hospitals and medical schools in sub-Saharan Africa with support from the Bristol-Myers Squibb Foundation. About 344 were trained between 2010 and 2013, the latest year for which information is available. Such practices are useful not only in clinical trial environments, but also in hospital and clinical settings where patients are assessed.
  • Other Examples of Capacity-Building for HIV in Africa:
    • The Bristol-Myers Squibb Foundation’s Legacy NGO Training Institute has trained more than 1,700 NGO leaders and managers in five countries about effective and efficient institutional and program management.
    • The Swaziland Breast and Cervical Cancer Network, which supports rural initiatives on HIV and cancer, established the first community-level cervical cancer screening clinic in May 2013.
    • People Living with Disabilities and HIV in Zimbabwe and South Africa facilitates empowerment programs to help people with disabilities advocate for their needs and gain access to information and resources. The organization’s work has informed policy to increase access to health and social services and HIV care for people with disabilities.
    • In South Africa, Ladysmith Regional Hospital’s HIV and Mental Health Program provides a coordinated and comprehensive care model that integrates health care services for mental health disorders, substance abuse and HIV/AIDS. The health district has adopted the hospital’s HIV testing guidelines as a best practice model.
  • Dedicated Children’s AIDS Clinics in Africa: Bristol-Myers Squibb – partnering with the Baylor International Pediatric AIDS Initiative and Texas Children’s Hospital – created five Children’s Clinical Centers of Excellence in Botswana, Lesotho, Swaziland, Tanzania and Uganda. In addition, the Foundation funded a $2 million satellite network of clinics in Lesotho. Today, about 97,000 patients are under care in these clinics and their satellite sites and more than 200,000 at the countries outreach sites – 85 percent of them children.
  • Teen Center in Botswana: In the 10 years since the Botswana-Baylor-Bristol-Myers Squibb Children’s Clinical Center of Excellence opened in Botswana, the average age of a child infected with HIV/AIDS in Botswana has risen from 5 years to 14 years as the increased availability of care and support have transformed HIV/AIDS into a manageable chronic disease. Now that more than half of the 4,000 children receiving treatment at the Botswana center are teenagers, these children have new needs. In 2013, the Bristol-Myers Squibb Foundation’s SECURE THE FUTURE program and Bristol-Myers Squibb employees donated money to help establish the Botswana-Baylor-Bristol-Myers Squibb Adolescent Centre of Excellence. The center provides care appropriate for teenagers, helping them manage medical, behavioral and psychosocial issues along with their illness and also teaching them how to manage their medication on their own. READ MORE.
  • Pediatric AIDS Corps: From 2006-11, the Bristol-Myers Squib Foundation, in partnership with the Baylor College of Medicine, collaborated on a $22 million program to establish the Pediatric AIDS Corps, where young pediatricians from the U.S. signed on for one- to two-year stints to work in the Bristol Myers Squibb-Baylor College of Medicine Children’s Clinical Centers of Excellence in Africa. At its peak, some 59 physicians were serving in these clinics at any one time. The Pediatric AIDS Corps also worked in a network of associated rural clinics, treating HIV-infected children and their families, and training other health care professionals. Each month, about 2,000 local health care providers received training in this network of clinics, while another 125 received more intensive clinical mentoring. In July 2011, the Pediatric AIDS Corps became the Texas Children’s Global Health Service Corps, broadening its mission to include other diseases afflicting sub-Saharan Africa beyond HIV.
  • Collaborating with the World Health Organization’s Global TB Program to address tuberculosis in Africa: Another important innovation by the Bristol-Myers Squibb Foundation focuses on the neglected problem of tuberculosis (TB) co-infections for HIV/AIDS patients. According to the World Health Organization (WHO), 80 percent of the world’s HIV/TB burden is in Africa, where South Africa is ranked second to Swaziland among areas most affected. Since 2011, the Bristol-Myers Squibb has supported WHO’s ENGAGE-TB initiative with more than $4.7 million in funding to strengthen the involvement of non-governmental organizations in community-based TB and TB/HIV care in South Africa, Tanzania, Kenya, Ethiopia and Democratic Republic of the Congo. The Foundation also has developed a TAP faculty offering based on successful SECURE THE FUTURE projects in South Africa. This approach integrates community outreach for adherence to tuberculosis and HIV treatment and management protocols with community-based approaches for education, case identification, rapid diagnosis and follow-up treatment. Since 2011, the Foundation’s partners in South Africa, Ethiopia, and Tanzania have screened nearly 32,000 people and referred 1,854 to care for TB.

Hepatitis B/C in Asia

Since 2002, the Bristol-Myers Squibb Foundation’s Delivering Hope program has supported more than 40 projects in China and India that have focused on the millions affected by hepatitis B (HBV) and hepatitis C (HCV) in the two countries.

These efforts have focused on empowering patients, families and communities; identifying and training community-based health “sentries” – lay, auxiliary and non-specialist health workers; seeking innovative channels for promoting disease awareness and education; and raising the profile of viral hepatitis as a public health issue. To date, Delivering Hope projects have trained more than 371,279 health workers, vaccinated more than 753,141 people against hepatitis B, and informed health policy in China and in India.

  • In India, Delivering Hope has supported the training of nearly 85,000 health workers. In addition, more than 153,000 patients have received HBV vaccination and 8,136 patients have been screened for viral hepatitis.
  • In China, Delivering Hope has supported the training of more than 133,000 health workers on HCV and nearly 4,000 more on HBV. In addition, about 128,000 women have been screened for HBV, nearly 6,200 screenings were done for family members of HBV and HCV patients, and nearly 3,500 people received HBV vaccinations.

To extend the impact of those projects in the future, in 2013 the Foundation established three new Centers of Excellence – to work with its grantees and other partners to use evidence-based practices from prior Foundation projects to help scale up and replicate additional community-based interventions and inform public policy in liver diseases.

One center is based at the Chinese Foundation for Hepatitis Prevention and Control (CFHPC) and the other two are in India, one at the Liver Foundation of West Bengal and a second at the HOPE Initiative in Uttar Pradesh. READ MORE.

In July 2013, Delivering Hope received a Best CSR Practices award in the “Concern for Health” category from CMO Asia.

In November 2012, to mark its 10th anniversary, Delivering Hope convened a Centers of Excellence Conference to share insights from Asian-Pacific community groups about the best approaches for managing viral hepatitis.

Cancer Care in Central & Eastern Europe

  • Another area of focus for the Foundation is the public health response to cancer in Central and Eastern Europe, particularly in connection with rising rates of breast and lung cancers, lack of hospice and family supportive care and stigma around cancer. Cancer is the second-most common cause of death in Europe and remains a significant public health problem. The incidence-to mortality ratios in Central and Eastern Europe tend to be less favorable than those in Northern and Western Europe. Low levels of cancer awareness and understanding among the general population, a lack of cancer prevention and screening efforts, and limited health care resources in the region are factors contributing to this gap.

    To address these disparities, the Foundation has been creating innovative partnerships focused on training oncology, general practice and public health nurses to increase their ability to care for cancer patients in the community, targeting funding at the community level and seeking to improve patient health outcomes and their quality of life through its Bridging Cancer Care program. Bridging Cancer Care focuses on populations disproportionately affected by cancer, including the poor, ethnic minorities and people living in rural communities with limited access to cancer services.

    Between 2010 and 2013 the Foundation has awarded 22 Bridging Cancer Care grants for projects in Russia, Poland, Czech Republic, Hungary and Romania:
  • In 2013, the Foundation awarded two, two-year grants totaling $700,000 to establish Cancer Nursing Centers of Excellence in oncology nursing and smoking cessation in Saratov Oblast, Russia, and Prague, Czech Republic. The centers will offer training and technical assistance to nurses and will disseminate lessons and impactful approaches to broader audiences throughout Central and Eastern Europe. READ MORE.
  • In 2012, the Foundation awarded five grants totaling about $750,000 to improve nursing skills for oncology, general practice and public health nurses in the Czech Republic, Poland, Romania and Russia. READ MORE.
  • In 2011, the Foundation awarded six grants totaling more than $900,000 to improve cancer awareness, prevention and care by developing cancer nursing skills and building nurse-community partnerships in Hungary, Poland, Romania and Russia. READ MORE
  • In 2010, the Foundation supported the implementation of the End of Life Nursing Education Consortium to improve palliative care in several countries, including Russia and Romania. Also in Romania, a two-year, $95,000 grant supported a project to increase health literacy and improve the quality of life for cancer patients by educating community nurses and forming partnerships between nurses, patients and libraries. A $149,000 grant to World Services of LaCrosse in Russia enhanced cancer nursing skills as well as increased health care system capacity for prevention, screening and care through expanding the scope of practice of the nursing role.


You are leaving to go to the Amylin Job Search and application tool. IMPORTANT TO NOTE: This may require a separate login and password than what is used for the Bristol-Myers Squibb search and application process.
You are leaving to go to the Amylin Job Search and application tool. IMPORTANT TO NOTE: This may require a separate login and password than what is used for the Bristol-Myers Squibb search and application process.